Elligo Health Research

Overview

Elligo Health Research, founded in 2016 and based in the United States, operates within the Business Services industry, particularly focusing on research and development in biotechnology and pharmaceuticals. The company specializes in enhancing clinical trial processes through innovative patient recruitment strategies. According to its published whitepaper, Elligo emphasizes the importance of a robust patient database, which provides access to a diverse population of over 100 million patients. This extensive reach is intended to facilitate patient enrollment and engagement in clinical trials, addressing common challenges in the recruitment process. The company advocates for patient-centric trial designs that view participants as informed collaborators rather than mere subjects, promoting active involvement in their healthcare. By prioritizing diversity in clinical research, Elligo aims to reduce health equity gaps and ensure that various demographic groups are adequately represented in studies. Overall, Elligo Health Research is positioned as a key player in transforming clinical trial methodologies through enhanced patient access and engagement strategies.

Industry